Analytical Data
-
Gene name
LRRC54
- Application
-
Alternative Names
TSKU; E2IG4; LRRC54; TSK; UNQ850/PRO1788Tsukushin; Tsukushi; E2-induced gene 4 protein; Leucine-rich repeat-containing protein 54
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8WUA8
-
Expression Region
1-353aa
-
AA Sequence
MPWPLLLLLAVSGAQTTRPCFPGCQCEVETFGLFDSFSLTRVDCSGLGPHIMPVPIPLDTAHLDLSSNRLEMVNESVLAGPGYTTLAGLDLSHNLLTSISPTAFSRLRYLESLDLSHNGLTALPAESFTSSPLSDVNLSHNQLREVSVSAFTTHSQGRALHVDLSHNLIHRLVPHPTRAGLPAPTIQSLNLAWNRLHAVPNLRDLPLRYLSLDGNPLAVIGPGAFAGLGGLTHLSLASLQRLPELAPSGFRELPGLQVLDLSGNPKLNWAGAEVFSGLSSLQELDLSGTNLVPLPEALLLHLPALQSVSVGQDVRCRRLVREGTYPRRPGSSPKVALHCVDTRDSAARGPTIL
-
Molecular Weight
64.46 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRRC54, or Leucine-Rich Repeat Containing 54, is a protein that has garnered attention in recent years due to its potential role in various biological processes, including cell signaling, immune response, and neurodevelopment. It belongs to the leucine-rich repeat (LRR) superfamily, which is known for its involvement in protein-protein interactions. The study of LRRC54 has been prompted by its expression patterns in multiple tissues, particularly in the brain and immune cells, suggesting that it may participate in crucial regulatory functions. Research has indicated that disturbances in LRRC54 expression could be linked to several diseases, including neurological disorders and immune-related conditions. As a result, there is a growing interest in developing recombinant LRRC54 protein for biochemical assays and functional studies to elucidate its mechanisms of action. Understanding the structure and function of LRRC54 could pave the way for new therapeutic strategies targeting the pathways it influences, thereby contributing to advancements in medical research. Given the significance of protein interactions in cellular function, LRRC54's role as a potential mediator in various diseases makes it a compelling subject for ongoing research in molecular biology and therapeutic development. This burgeoning field aims to define the exact contributions of LRRC54 to health and disease, as well as explore its potential as a biomarker or therapeutic target, thus highlighting the importance of LRRC54 recombinant protein research in the context of modern biomedical science.
